Literature DB >> 14576946

Histologic and immunohistochemical characterization of tumor and inflammatory infiltrates in oral squamous cell carcinomas treated with local multikine immunotherapy: the macrophage at the front line.

Meora Feinmesser1, Elimelech Okon, Ariel Schwartz, Ella Kaganovsky, Britta Hardy, Elena Aminov, Ben Nageris, Jaqueline Sulkes, Raphael Feinmesser.   

Abstract

Squamous cell carcinomas of the head and neck (SCCHN) are excellent candidates for local immunotherapy owing to their accessibility and their infiltration by mononuclear cells that are susceptible to immunomodulation. A response rate of 25-60% has been reported for treatment with natural IL-2 or a mixture of natural lymphokines. In the present study, biopsies and posttreatment excision specimens from nine patients with operable SCCHN treated systemically with a variety of immunomodulators and locally with natural lymphokines (multikine, CelSci) were analyzed in an attempt to correlate clinical response to histopathological and immunohistochemical changes. Formalin-fixed, paraffin-embedded tissues were stained with antibodies against lymphocytes (CD45, CD3, CD4, CD8, CD20), macrophages (CD68) including dendritic cells (S-100), markers for lymphocyte activation (CD30, HLA-DR), natural killer cells (CD56 and CD57), beta-2-microglobulin and keratin. One patient showed a complete response to treatment and two a partial response. Tumor size was significantly smaller after therapy. Clinical and pathological regression were more prominent in the smaller tumors. Numerous macrophages, both mononucleated and multinucleated, were present along the tumor-stroma interface in the posttreatment specimens of seven patients, most prominently in the three patients with tumor regression. The increase in the number of CD68+ and S-100+ macrophages after treatment was statistically significant. Lymphocytic infiltrates, which showed some increase following treatment, were composed of a mixture of T and B lymphocytes, the former mostly in contact with the tumor and the latter placed more peripherally. CD8+ lymphocytes extended into the tumors, whereas CD4+ lymphocytes showed minimal extension. Intensity of beta-2-microglobulin staining in tumors was significantly higher following therapy and associated with a better outcome. The marked increase in macrophages following treatment may indicate that the macrophage plays a major role in tumor recognition, destruction and clearance. An increase in the number of macrophages in a posttreatment specimen may indicate immunoresponsiveness.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14576946     DOI: 10.1007/s00405-003-0615-x

Source DB:  PubMed          Journal:  Eur Arch Otorhinolaryngol        ISSN: 0937-4477            Impact factor:   2.503


  43 in total

1.  Differential sensitivity of head and neck cancers to non-major histocompatibility-restricted killer cell activity.

Authors:  S P Schantz; T Racz; N G Ordonez; N Terry; D L Taylor; S Bugis; P G Sacks
Journal:  J Surg Res       Date:  1990-02       Impact factor: 2.192

2.  Tumor differentiation-dependent local immunity in human head and neck cancers.

Authors:  I Arany; K Adler-Storthz; Z Chen; S K Tyring; M M Brysk
Journal:  Cancer Lett       Date:  1998-01-30       Impact factor: 8.679

3.  Immune complexes, serum proteins, cell-mediated immunity, and immune regulation in patients with squamous cell carcinoma of the head and neck.

Authors:  R W Veltri; S M Rodman; P E Maxim; M W Baseler; P M Sprinkle
Journal:  Cancer       Date:  1986-06-15       Impact factor: 6.860

4.  Treatment of recurrent squamous cell carcinoma of the head and neck with low doses of interleukin-2 injected perilymphatically.

Authors:  G Cortesina; A De Stefani; M Giovarelli; M G Barioglio; G P Cavallo; C Jemma; G Forni
Journal:  Cancer       Date:  1988-12-15       Impact factor: 6.860

5.  The expression of cell surface MHC class I heavy and light chain molecules in pre-malignant and malignant lesions of the oral mucosa.

Authors:  S S Prime; A Pitigala-Arachchi; I J Crane; T J Rosser; C Scully
Journal:  Histopathology       Date:  1987-01       Impact factor: 5.087

6.  Evidence for the role of natural immunity in the control of metastatic spread of head and neck cancer.

Authors:  S P Schantz; B W Brown; E Lira; D L Taylor; N Beddingfield
Journal:  Cancer Immunol Immunother       Date:  1987       Impact factor: 6.968

7.  Phase Ib trial of the effect of peritumoral and intranodal injections of interleukin-2 in patients with advanced squamous cell carcinoma of the head and neck: an Eastern Cooperative Oncology Group trial.

Authors:  D R Vlock; C H Snyderman; J T Johnson; E N Myers; D E Eibling; J S Rubin; J M Kirkwood; J P Dutcher; G L Adams
Journal:  J Immunother Emphasis Tumor Immunol       Date:  1994-02

8.  Mitogen responsiveness and inhibitory activity of mesenteric lymph node cells. Conditioned medium containing T cell growth factor reverses suppressor function.

Authors:  B M Vose; R Ferguson; M Moore
Journal:  Cancer Immunol Immunother       Date:  1982       Impact factor: 6.968

9.  Evidence for local and systemic activation of immune cells by peritumoral injections of interleukin 2 in patients with advanced squamous cell carcinoma of the head and neck.

Authors:  T L Whiteside; E Letessier; H Hirabayashi; D Vitolo; J Bryant; L Barnes; C Snyderman; J T Johnson; E Myers; R B Herberman
Journal:  Cancer Res       Date:  1993-12-01       Impact factor: 12.701

10.  Temporary regression of recurrent squamous cell carcinoma of the head and neck is achieved with a low but not with a high dose of recombinant interleukin 2 injected perilymphatically.

Authors:  G Cortesina; A De Stefani; E Galeazzi; G P Cavallo; F Badellino; G Margarino; C Jemma; G Forni
Journal:  Br J Cancer       Date:  1994-03       Impact factor: 7.640

View more
  3 in total

1.  Polyinosinic-cytidylic acid as an adjuvant on natural killer- and dendritic cell-mediated antitumor activities.

Authors:  Yu-Kun Huang; Zhi Zheng; Fu Qiu
Journal:  Tumour Biol       Date:  2013-02-22

2.  Fucoidan reduced the invasion of oral squamous cell carcinoma cells and modified their effects to macrophages.

Authors:  Junda Lin; Ketao Wang; Huayang Wang; Qianqian Shao; Yijun Luan; Yan Xu; Xiaobin Song; Wanye Tan; Shaohua Liu; Fengcai Wei; Xun Qu
Journal:  Med Oncol       Date:  2016-12-21       Impact factor: 3.064

3.  Overexpression of beta2-microglobulin is associated with poor survival in patients with oral cavity squamous cell carcinoma and contributes to oral cancer cell migration and invasion.

Authors:  C-H Chen; C-Y Su; C-Y Chien; C-C Huang; H-C Chuang; F-M Fang; H-Y Huang; C-M Chen; S-J Chiou
Journal:  Br J Cancer       Date:  2008-10-07       Impact factor: 7.640

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.